Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

ESR1 Gene Mutation 1Breast Neoplasms 1

Interventions

elacestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × ESR1 Gene Mutation × elacestrant × Clear all
NCT06544577 2024-08-09

Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC

SciClone Pharmaceuticals

Recruiting
350 enrolled
Breast

ESR1 Gene Mutation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡